ReviewFrontiers in psychiatry2021

Clinical Trials of Cannabidiol for Substance Use Disorders: Outcome Measures, Surrogate Endpoints, and Biomarkers.

Alix Morel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.